London, June 23: Amid controversies regarding the safety of silicon breast implants, the US drug regulators' report is sure to give some relief to women contemplating to go under the knife.

The Food and Drug Administration (FDA) has said that the implants are relatively safe, despite frequent complications and a small increased risk of the disease lymphoma.

However, in order to help people make informed decisions, the report revealed that as many as one in five breast augmentation patients had the implants removed within 10 years.

The FDA reported that studies have found no association between the silicone implants and connective tissue disease, breast cancer or reproductive problems.

But the `very small' increased risk of anaplastic large cell lymphoma linked with silicon implants cannot be ruled out.

The report noted that the risk of local complications from the implants, such as implant rupture, wrinkling, asymmetry, scarring, pain and infection increases with time.

"Breast implants are not lifetime devices. The longer you have your implants, the more likely it will be for you to have them removed," the BBC quoted FDA as saying.

However, the agency also found that most women who had breast implants "report high levels of satisfaction with their body image and the shape, feel and size of their implants."

Although, the controversy may not have come to an end, the recent report is sure to clear misconceptions of people associated with silicon breast implants. (ANI)